Infinity Pharmaceuticals

$1.79
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.19 (-9.50%) Today

-$0.02 (-1.10%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell INFI and other stocks, options, and ETFs commission-free!

About INFI

Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA. The listed name for INFI is Infinity Pharmaceuticals, Inc. Common Stock.

CEO

Adelene Q. Perkins

Employees

Headquarters

Cambridge, Massachusetts

Founded

1995

Market Cap

116.21M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.02M

High Today

$2.04

Low Today

$1.80

Open Price

$2.04

Volume

1.08M

52 Week High

$2.17

52 Week Low

$0.60

Collections

INFI Earnings

-$0.24

-$0.13

-$0.03

$0.08

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 3